Cefzlora 50 Dry Syrup contains Cefixime 50mg/5ml, a third-generation cephalosporin antibiotic indicated for the treatment of pediatric bacterial infections. It helps manage infections of the respiratory tract, ENT, urinary tract, and skin, ensuring rapid relief and recovery in children.
Cefixime works by inhibiting bacterial cell wall synthesis, effectively eliminating susceptible bacteria. Its broad-spectrum activity and palatable dry syrup formulation make it ideal for pediatric dosing, accuracy, and compliance.
This formulation ensures precise dosing for children and is widely recommended by pediatricians for mild to moderate bacterial infections. Cefzlora 50 Dry Syrup is a high-demand pediatric antibiotic product across hospitals, clinics, and community health programs.
Adding Cefzlora 50 Dry Syrup to your pediatric antibiotic segment strengthens your portfolio with a trusted cephalosporin therapy. Its prescriber preference, consistent demand, and suitability for domestic and export markets make it a valuable addition to pharmaceutical distribution portfolios.